ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Sonoma Pharmaceuticals (SNOA)

Technical Analysis Report for NASDAQ stock SNOA Sonoma Pharmaceuticals. Dated: 26 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock SNOA Sonoma Pharmaceuticals then click here. or read Experts views on Sonoma Pharmaceuticals or Forecast & share price targets of Sonoma Pharmaceuticals

Sonoma Pharmaceuticals Opened at 3.60 and Closed at: 3.61, which is -0.83% of previous session's close. It moved within a range of 3.46 and 3.68
The session was a Bullish session with an average volume of 32400, which is 78.09% of previous session's volumes.

  • Even though the stock has fallen, but its short term trend is positive and in an uptrend.

Support for tomorrow is 3.54 and resistance for tomorrow is 3.76
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 3.49, 3.36 resistance for tomorrow's hourly charts is 3.71, 3.8

10 Day SMA for Sonoma Pharmaceuticals (SNOA) is 3.56 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Sonoma Pharmaceuticals (SNOA) is 3.51 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Sonoma Pharmaceuticals (SNOA) is 3.61 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 3.95 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Sonoma Pharmaceuticals is 3.52 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Sonoma Pharmaceuticals is at 3.51 and 200 DMA is at 3.52, while 50 DMA and 100 DMA are at 3.61 and 3.95 respectively

Sonoma Pharmaceuticals (SNOA) moving average of 20 SMA is at 3.51 and 20 EMA is at 3.56

Sonoma Pharmaceuticals (SNOA) moving average of 50 SMA is at 3.61 and 50 EMA is at 3.64

Sonoma Pharmaceuticals (SNOA) moving average of 100 SMA is at 3.95 and 100 EMA is at 3.68

Sonoma Pharmaceuticals (SNOA) moving average of 200 SMA is at 3.52 and 200 EMA is at 3.42

Sonoma Pharmaceuticals has performed better than Strata Skin in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Sanofi in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Repligen Corporation in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Outlook Therapeutics in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Ocular Therapeutix in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Kezar Life in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Arbutus Biopharma in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Agios Pharmaceuticals in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Autolus Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Autolus Therapeutics, about 10.03% more returns!

Sonoma Pharmaceuticals has performed better than Axsome Therapeutics in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Capricor Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 446.54% more returns!

Sonoma Pharmaceuticals has performed better than Cellectar Biosciences in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Cytokinetics Incorporated in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Fortress Biotech has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Fortress Biotech, about 27.68% more returns!

Heron Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Heron Therapeutics, about 1.93% more returns!

Sonoma Pharmaceuticals has performed better than Ionis Pharmaceuticals in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals Technical analysis of indicators

Price action analysis of Sonoma Pharmaceuticals (SNOA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Sonoma Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

MACD generated a BUY signal for Sonoma Pharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Sonoma Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Sonoma Pharmaceuticals in short term but SELL signal is weak.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Sonoma Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 3.54 and Sonoma Pharmaceuticals SNOA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Sonoma Pharmaceuticals SNOA stock. Volume based technical analysis of Sonoma Pharmaceuticals SNOA stock is negative.

Sonoma Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock SNOA Sonoma Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And SNOA Experts View which covers a lot of information including buying and selling signals

SNOA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Sonoma Pharmaceuticals or View Candle Stick Charts here

Chart Sonoma Pharmaceuticals (SNOA)  Technical (Analysis) Reports Sonoma Pharmaceuticals [

Videos related to: Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Sonoma Pharmaceuticals (SNOA)  Technical (Analysis) Reports Sonoma Pharmaceuticals [

 

Back to top